Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Operations (Unaudited)

v3.21.1
Condensed Consolidated Statements of Operations (Unaudited) - USD ($)
$ in Thousands
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Revenues:    
Total revenues $ 4,030 $ 3,116
Cost of revenues 1,416 932
Research and development costs 1,563 818
Sales and marketing expenses 1,575 1,299
General and administrative expenses 1,657 1,276
Operating loss (2,181) (1,209)
Other expense:    
Other expense, net (25) (4)
Interest expense, net (332) (842)
Net loss $ (2,538) $ (2,055)
Net loss per share attributable to common stockholders:    
Basic and diluted $ (0.13) $ (0.13)
Weighted average shares outstanding:    
Basic and diluted 18,852,828 15,438,276
Product Revenue    
Revenues:    
Total revenues $ 3,162 $ 2,179
Service and Other Revenue    
Revenues:    
Total revenues $ 868 $ 937